Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Liver Enzyme CYP2D6 Gene and Tardive Dyskinesia

Pharmacogenomics(2020)10.2217/pgs-2020-0065Source: DataRank Database

Liver Enzyme CYP2D6 Gene and Tardive Dyskinesia is a research paper published in Pharmacogenomics (2020). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

Linked data & code

refsnp doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (27 grants)OA: greenTopics (45)IDs (PubMed, PMC)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Arun K. Tiwari ORCID,Natalie Freeman,Gwyneth Zai,Vincenzo De Luca ORCID,Daniel J. Müller ORCID

Live enrichment

PubMed:32969762 PMC:PMC7586356

Canadian Institutes of Health Research

Grant: MOP 142192

NIMH NIH HHS

Grant: R01 MH085801

Canadian Institutes of Health Research

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5R01MH085801-05

Mitochondrial Abnormalities in Schizophrenia and Bipolar Disorder

BiolineRx.

Janssen

Canadian Foundation

Roche and Eli Lilly corporations

Sunovion

Tanabe Pharma Corporation,

Abbott Labs

Bristol Myers Squibb

Canadian Institutes of Health Research

National Institutes of Health

CAMH Foundation

CC Zai, AK Tiwari, DJ DJ Müller and JL Kennedy

Eli Lilly, EnVivo

Genomic Applications Partnership Program

HY Meltzer

Otsuka

Pfizer,

Roche

ACADIA

Alkemes

DaiNippon Sumitomo

Ministry of Research and Innovation of Ontario

Pierre Fabre

greenLicense: CC BY

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7586356

publisherhttps://www.tandfonline.com/doi/pdf/10.2217/pgs-2020-0065

repositoryhttps://escholarship.org/uc/item/5q36f57b

https://doi.org/10.2217/pgs-2020-0065

https://europepmc.org/articles/pmc7586356?pdf=render

Fields of Study

03 medical and health sciences0302 clinical medicineAdultAntipsychotic AgentsCytochrome P-450 CYP2D6FemaleHumansLiverMaleMiddle AgedSchizophreniaTardive DyskinesiaWhite People

MeSH Terms

LiverHumansCytochrome P-450 CYP2D6Antipsychotic AgentsSchizophreniaAdultMiddle AgedFemaleMaleTardive DyskinesiaWhite People

Keywords

SchizophreniaCYP2D6Tardive DyskinesiaPharmacogeneticsMetabolizer PhenotypeAdultMaleMedical and Health SciencesWhite PeopleGeneticsHumansPharmacology & PharmacyBiomedical and Clinical SciencesPharmacology and Pharmaceutical SciencesBiological SciencesMiddle AgedCytochrome P-450 CYP2D6LiverMental healthFemaleAntipsychotic Agents

Sustainable Development Goals

SDG 2: 2. Zero hungerSDG 3: 3. Good health

Liver Enzyme CYP2D6 Gene and Tardive Dyskinesia

FAIR Checklist

Authors (18)

Funding (27 grants)

Open Access

Topics

Annotations (Europe PMC)